Template:SPCaripiprazoleLA

From Psychiatrienet
Revision as of 12:29, 20 February 2025 by Casper (talk | contribs)
Jump to: navigation, search
  • More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. [1]
  • Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg (once a month) and 960mg (once every two months) preparations. A reduced dose of 75% (300mg and 720mg respectively) can be needed when experiencing side effects.
  • ↑ https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot
    • Retrieved from "https://wiki.psychiatrienet.nl/w/index.php?title=Template:SPCaripiprazoleLA&oldid=10313"